100% human monoclonal antibodies in oncology: hype or breakthrough?

Benay, Stephan; Fanciullino, Raphaelle; Mercier, Cedric; Iliadis, Athanassios; Ciccolini, Joseph; Lacarelle, Bruno

Benay, Stephan; Fanciullino, Raphaelle; Mercier, Cedric; Iliadis, Athanassios; Ciccolini, Joseph; Lacarelle, Bruno.

Affiliation

Benay S; Laboratoire de Pharmacocinetique - UFR Pharmacie, 27 Bd Jean Moulin, 13385 Marseille, France.

Curr Top Med Chem ; 12(15): 1643-8, 2012.

Article in En | MEDLINE | ID: mdl-22978333

Subject(s)

Antibodies, Monoclonal/therapeutic use; Antineoplastic Agents/therapeutic use; Colorectal Neoplasms/drug therapy; Molecular Targeted Therapy; Antibodies, Monoclonal/administration & dosage; Antibodies, Monoclonal/pharmacokinetics; Antineoplastic Agents/administration & dosage; Antineoplastic Agents/pharmacokinetics; Clinical Trials as Topic; Colorectal Neoplasms/metabolism; Colorectal Neoplasms/mortality; Colorectal Neoplasms/pathology; Disease-Free Survival; Humans; Molecular Targeted Therapy/methods; Molecular Targeted Therapy/trends; Panitumumab

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Colorectal Neoplasms / Molecular Targeted Therapy / Antibodies, Monoclonal / Antineoplastic Agents Limits: Humans Language: En Journal: Curr Top Med Chem Journal subject: QUIMICA Year: 2012 Document type: Article Affiliation country: France Country of publication: United Arab Emirates

Search on Google

Add to My VHL

XML

PubMed Links